Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

cbdMD (YCBD) Change in Accured Expenses (2016 - 2025)

cbdMD's Change in Accured Expenses history spans 10 years, with the latest figure at -$276942.0 for Q4 2025.

  • For Q4 2025, Change in Accured Expenses fell 16.97% year-over-year to -$276942.0; the TTM value through Dec 2025 reached -$302055.0, up 79.91%, while the annual FY2025 figure was -$261883.0, 76.7% up from the prior year.
  • Change in Accured Expenses for Q4 2025 was -$276942.0 at cbdMD, down from -$67251.0 in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $763157.0 in Q2 2021 and bottomed at -$1.6 million in Q3 2024.
  • The 5-year median for Change in Accured Expenses is -$53808.0 (2025), against an average of -$168466.0.
  • The largest annual shift saw Change in Accured Expenses crashed 1494.93% in 2023 before it surged 20577.44% in 2025.
  • A 5-year view of Change in Accured Expenses shows it stood at -$127254.0 in 2021, then soared by 130.81% to $39204.0 in 2022, then skyrocketed by 262.95% to $142292.0 in 2023, then tumbled by 266.4% to -$236770.0 in 2024, then dropped by 16.97% to -$276942.0 in 2025.
  • Per Business Quant, the three most recent readings for YCBD's Change in Accured Expenses are -$276942.0 (Q4 2025), -$67251.0 (Q3 2025), and $82503.0 (Q2 2025).